Alvotech (ALVO) Other Operating Expenses (2025)

Alvotech (ALVO) posted Other Operating Expenses of -$600000.0 for Q4 2025.

Alvotech (ALVO) Other Operating Expenses (2025) Analysis & Trends

Alvotech's Other Operating Expenses history runs 1 years deep, the most recent figure standing at -$600000.0 for Q4 2025.

  • Quarterly Other Operating Expenses changed N/A year-over-year to -$600000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$600000.0 (changed N/A YoY) and the FY2025 annual result came in at $58.1 million, up 120.24% from the prior year.
  • Other Operating Expenses was -$600000.0 for Q4 2025 at Alvotech.
  • Across five years, Other Operating Expenses topped out at -$600000.0 in Q4 2025 and bottomed at -$600000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 88.07 Bn 86.20 Bn -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn
10 Alvotech 899.08 Mn 899.08 Mn 5.09 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -600,000.00